Press Release
When Pain Points in Cross-Border Payment Brings Payment Changes, How Can Hypercard Lead the Trend
Throughout the evolving history of global cross-border payment, cross-border payment is rising with the continuous development of the international division of labor and international exchanges. In the early days, people use precious metals for cross-border payment and clearing, then followed by paper money, and today’s modern electronic transfer and clearing. Cross-border payment is developing gradually towards a rapid, safe and economical trend as the entire international community is engaging in the activities more frequently and science and technology are changing and progressing.
The change of cross-border payment
According to the data, the total amount of global cross-border payment reached $125 trillion in 2018 and is expected to reach $218 trillion in 2022, promising huge profits.

In the existing transfer and remittance system, the transaction is slow and the cost is high with much margin for error; institutions have to coordinate the value transfer between different internal databases, which makes it extremely difficult to settle transactions quickly. This process not only slows down the transaction progress but also requires large working capital, which has a negative impact on the balance sheet of the institution.
As cryptoassets are gradually accepted by traditional finance, digital currency payment is also implementing and applying quickly. The competition around digital currency has just begun across the globe. In 2019, the emergence of Libra has triggered the catfish effect, and legal currency is discussed more enthusiastically all over the world. Countries have taken precautions and speeded up the research on sovereign digital currency. Even the European Central Bank, which did not seem interested before, recently began to discuss the necessity of developing a unified digital currency. According to a report released by the International Monetary Fund in July of the same year, nearly 70% of the world’s central banks are studying sovereign digital currency.
Some fear that Libra may become a strong currency once in circulation. It can be exchanged with the currencies of countries and erodes the fiat currency. If the weak countries make mistakes in regulation, hyperinflation or even de-monetization will likely happen. In the past, a typical example is Zimbabwe who abolished its local currency and was forced to use the US dollar and other currencies.
Traditional payment giants are fostering digital currency payment
Bitcoin was born to destroy the existing monetary system, which many people think is too expensive and exclusive. Given this, it has a much broader value proposition than a deflationary policy and a hard cap of 21 million coins. The new application of blockchain technology also allows anyone to remit money to counterparties around the world in minutes at a low cost.
This function makes bitcoin directly target the existing payment platforms (such as credit card networks and inter-bank messaging systems). While some companies shrug off these concerns, others see the potential and are looking for ways to create value for partners and shareholders.
According to news on February 20, Visa, an international payment giant, has cooperated with 35 leading digital currency platforms or digital wallets.
These institutions are digital currency platforms licensed by the state or regulated by relevant departments, such as the digital payment platform WireX, the digital currency trading platform Coinbase and Fold, cryptoasset lending platform BlockFi, Austria encryption trading platform Bitpanda, Encrypted debit card platform Crypto.com, etc.
Industry insiders said that the cooperation between Visa and digital currency service providers enables consumers to exchange digital currency more quickly and easily. Users can also deposit this money into their Visa certificates in real-time.
When asked why Visa chose the cryptoasset payment, Visa’s executives clearly expressed their optimism about the payment method in his talks with Forbes: “we saw significant innovation in new financial services for consumers holding digital currency. One example is the growth in demand for digital money lending. We are delighted to work with fintech companies like Cred. The company develops new products in this ecosystem and finds new ways for Visa to improve the entrance of fiat currency associated with these products. “
At present, in addition to Visa, MasterCard, Paypal and other international payment tycoons are also fostering digital currency.
Recently, MasterCard stated that it has cooperated with the Central Bank of The Bahamas to launch the world’s first Bahamas prepaid card. The prepaid card allows people to immediately exchange digital currency into traditional Bahamas dollars and pay for goods and services anywhere MasterCard supports. PayPal also claimed to provide cryptocurrency services to the UK market in the coming months.
Cryptoasset service providers speed up the participation in payment
Not only the traditional payment giants are paying attention to cryptoassets payment, but also the asset service providers in the encryption industry are exploring the possibility of payment. HyperBC, a well-known encrypted asset service provider, has launched a comprehensive consumer card HyperCard. After being deposited with digital currency, the card is available in more than 176 countries and more than 50 million merchants worldwide.
As a global standard credit card, HyperCard supports the binding consumption with third-party payment companies by users
Every payment made by HyperCard is secure and consumer privacy is protected by law. HyperCard can transfer money beyond the geographical limit in a second at a low commission, yet with 24/7 service. It is traceable with clear information of all parties. No matter which city you are in, you can use it at all merchants accepting Visa, Master and UnionPay.

In fact, in addition to payment, the most intuitive appealing of digital currency credit cards is it makes encrypted assets purchasing easy and cash out of cryptoassets. In this context, digital currency payment is still a very new track, and the choice of such products is still limited. The main problems are as follows:
1. Only single-currency payment is supported, such as bitcoin
2. Only available in a small number of areas
3. Users have to buy cryptocurrency issued by the card providers before paying
4. Charge a certain percentage of the annual fee
HyperBC also takes this situation into consideration. It is convenient to apply for HyperCard. The digital currency, deposited into HyperCard, can be exchanged into fiat currency in real-time, eliminating the tedious process and the trouble of cash payment, and significantly improving the user-friendliness of digital currency. HyperCard does not charge for KYC verification and only charges a very low commission for each deposit.

How to apply for HyperCard?
a Download the HyperPay App(https://www.hyperpay.tech/app_down) and register
b Apply for HyperCard

c Submit KYC documents and pass the certification

d HyperCard received
Conclusion
With the rapid development of digital currency and the increasing global acceptance of digital currency, the boundary between fiat currency and digital currency will become narrower. At the same time, digital currency credit card reduces the threshold for traditional users to access digital currency. The selective digital currency assets also avoid their risk in holding digital currency to a certain extent, Whether for investment, quick cash-out, or regular consumption, HyperCard, as a mature digital currency credit card, can enable cardholders to enjoy more convenient services.
About Author
Disclaimer: The views, suggestions, and opinions expressed here are the sole responsibility of the experts. No Digi Observer journalist was involved in the writing and production of this article.
Press Release
Health Connect Alliance Names CoreAge Rx Best GLP-1 Provider for Weight Management in 2026, Awards 9.9-10 Rating and Editor’s Choice Designation
Miami, FL 33101, United States, 18th Feb 2026 –Health Connect Alliance, an independent health education platform that provides reviews and guidance on GLP-1 medications and treatment providers, has released its rankings of telehealth platforms offering GLP-1 medications and named CoreAge Rx as the #1 recommended provider for weight management in 2026. The independent review evaluated more than 48 GLP-1 providers and awarded CoreAge Rx a 9.9 out of 10 rating, along with its Editor’s Choice designation and an A+ rating.

According to Health Connect Alliance, the rankings were based on key evaluation criteria including medical supervision, medication quality, treatment personalization, pricing transparency, and ongoing medical support. CoreAge Rx ranked at the top of the platform’s “Best Place to Get GLP-1 Medications” category, receiving the highest score among all reviewed providers.
The rankings page published by Health Connect Alliance lists CoreAge Rx as its #1 recommended GLP-1 provider, highlighting its premium GLP-1 program, access to FDA-approved semaglutide and tirzepatide, personalized treatment plans, and care provided under the supervision of board-certified physicians. The review also identifies CoreAge Rx as its “Editor’s Choice,” recognizing it as the platform’s top overall recommendation for GLP-1 treatment programs.
In its overall recommendation, Health Connect Alliance states that CoreAge Rx stands out as its top choice for individuals seeking GLP-1 medications for weight management. The platform notes that CoreAge Rx offers personalized treatment plans designed by board-certified physicians and provides ongoing medical supervision throughout treatment.
Health Connect Alliance’s editorial analysis outlines several factors that contributed to CoreAge Rx receiving the highest rating. One of the primary factors is medical supervision, which the platform identifies as a critical requirement for safe and legitimate GLP-1 treatment. The review emphasizes that reputable providers must require consultation with licensed healthcare professionals, conduct comprehensive health evaluations, and provide ongoing medical monitoring. CoreAge Rx was recognized for offering treatment programs overseen by board-certified physicians, ensuring clinical oversight throughout the treatment process.
Medication quality and sourcing were also identified as essential components in the rankings. Health Connect Alliance states that high-quality GLP-1 providers offer FDA-approved medications such as semaglutide and tirzepatide or compounded medications prepared by licensed compounding pharmacies that follow regulatory standards. The platform highlights that CoreAge Rx offers FDA-approved semaglutide and tirzepatide as part of its GLP-1 program.
Health Connect Alliance also notes the importance of personalized treatment plans in achieving successful outcomes. According to the review, personalized treatment plans allow healthcare providers to assess patient medical history, monitor progress, and adjust treatment protocols as needed. CoreAge Rx was recognized for providing individualized treatment plans developed and supervised by board-certified physicians.
The platform further emphasizes the importance of ongoing medical support throughout treatment. Health Connect Alliance explains that ongoing medical supervision allows healthcare providers to monitor progress, address potential side effects, and ensure safe and effective treatment. CoreAge Rx’s program includes ongoing medical support as part of its treatment structure, which contributed to its top ranking.
Health Connect Alliance’s review also provides broader clinical context about GLP-1 medications and their role in weight management. GLP-1 receptor agonists, including semaglutide and tirzepatide, mimic a naturally occurring hormone involved in regulating appetite and blood sugar. These medications slow gastric emptying, increase feelings of fullness, reduce appetite signals, and help stabilize blood sugar levels.
According to Health Connect Alliance, clinical research has shown that semaglutide may support reductions of approximately 10–15% of body weight, while tirzepatide may support reductions of approximately 15–26% when combined with lifestyle modifications and medical supervision. The platform notes that treatment outcomes vary based on individual health factors and adherence to treatment protocols.
Health Connect Alliance also explains that telehealth providers have expanded access to GLP-1 medications by enabling patients to complete medical consultations remotely and receive prescribed medications through direct-to-door delivery. The platform states that telehealth-based treatment programs can offer convenience, accessibility, and structured medical supervision.
As part of its rankings, Health Connect Alliance compared CoreAge Rx with other GLP-1 providers including Mochi Health, Ro, Noom, Remedy Meds, Hers, MEDVI, Eden, MyStart, and Clinic Secret. CoreAge Rx achieved the highest rating among all reviewed providers and was named the platform’s #1 overall recommendation.
Health Connect Alliance’s evaluation framework emphasizes that individuals seeking GLP-1 medications should verify provider medical credentials, confirm medication sourcing, review treatment policies, and ensure that licensed healthcare professionals are involved in prescribing and monitoring treatment.
The organization also highlights that legitimate GLP-1 providers require medical consultation prior to prescribing medication. This consultation allows licensed healthcare professionals to evaluate patient medical history, assess treatment eligibility, and ensure appropriate clinical oversight.
Health Connect Alliance describes its rankings and provider reviews as educational resources designed to help individuals make informed decisions about GLP-1 treatment programs. The platform states that its evaluation methodology focuses on medical supervision, treatment quality, safety standards, and transparency.
With its 9.9 out of 10 rating, Editor’s Choice designation, and #1 overall ranking among more than 48 reviewed providers, CoreAge Rx emerged as Health Connect Alliance’s highest-rated GLP-1 provider for weight management in 2026, reflecting the platform’s evaluation of medical supervision, personalized treatment plans, and access to FDA-approved semaglutide and tirzepatide.
For more info, visit: https://www.healthconnectalliance.com/glp-1/best
Media Contact
Organization: Health Connect Alliance
Contact Person: Ro Budo
Website: https://www.healthconnectalliance.com/
Email: Send Email
Contact Number: +13055550329
City: Miami
State: FL 33101
Country:United States
Release id:41550
The post Health Connect Alliance Names CoreAge Rx Best GLP-1 Provider for Weight Management in 2026, Awards 9.9-10 Rating and Editor’s Choice Designation appeared first on King Newswire. This content is provided by a third-party source.. King Newswire makes no warranties or representations in connection with it. King Newswire is a press release distribution agency and does not endorse or verify the claims made in this release. If you have any complaints or copyright concerns related to this article, please contact the company listed in the ‘Media Contact’ section
About Author
Disclaimer: The views, suggestions, and opinions expressed here are the sole responsibility of the experts. No Digi Observer journalist was involved in the writing and production of this article.
Press Release
Review Milestone: Why 300+ Patients Rated CoreAge Rx Among the Best in Online Weight Management Telehealth
Wichita Falls, TX 76302, United States, 18th Feb 2026 – CoreAge Rx, a telehealth platform focused on weight management and prescription treatment delivered through a fully online model, has reported a significant review milestone, with more than 300 patients providing positive feedback highlighting the platform’s onboarding experience, ongoing support, and overall care journey. According to CoreAge Rx, the growing number of patient reviews reflects a streamlined telehealth experience designed to provide accessible and professionally supervised weight management services.

The milestone underscores CoreAge Rx’s continued focus on delivering weight management care through a digital platform that allows patients to complete consultations remotely, receive physician evaluation, and access prescription treatment when appropriate. The company states that patient feedback consistently points to the clarity of the onboarding process and the structured approach to guiding patients through each stage of their care.
According to information provided by CoreAge Rx, patients begin the process by completing an online health assessment, which is reviewed by licensed medical professionals. This evaluation allows physicians to determine eligibility and develop individualized treatment plans based on each patient’s medical profile and weight management goals. The company reports that this structured onboarding system helps ensure that patients understand their care plan and receive appropriate medical supervision.
CoreAge Rx reports that ongoing support is another key factor contributing to patient satisfaction. Rather than limiting care to a one-time consultation, the platform provides continued access to medical guidance and treatment monitoring. Patient reviews provided to the company highlight the importance of continued communication and support throughout the weight management process, allowing patients to remain engaged and informed as they progress through treatment.
The company states that its telehealth platform is designed to remove many of the traditional barriers associated with in-person care. By enabling patients to complete evaluations and receive prescriptions remotely, CoreAge Rx provides a convenient alternative to traditional clinic visits. This remote care model allows patients to access weight management services from their home environment, reducing the need for travel and scheduling constraints.
CoreAge Rx also reports that physician supervision is a central component of its care model. According to the company, board-certified medical professionals review patient information, determine eligibility, and prescribe medications when appropriate. This physician-guided approach helps ensure that treatment decisions are based on individual health profiles and medical evaluation.
The company further states that prescription medications, when approved, are shipped directly to patients, allowing individuals to begin treatment without delays associated with traditional pharmacy visits. This delivery model supports the company’s goal of providing accessible and convenient weight management care through its telehealth platform.
According to CoreAge Rx, the review milestone reflects the company’s continued growth and patient engagement in the telehealth weight management space. The company reports that patient feedback consistently highlights the structured onboarding process, physician-guided care, and ongoing support as key factors contributing to the overall patient experience.
CoreAge Rx states that its digital-first approach is designed to provide patients with a clear and structured pathway, beginning with initial assessment, followed by physician evaluation, treatment approval when appropriate, and continued support. This step-by-step process is intended to ensure that patients receive care aligned with their individual needs.
The company reports that its telehealth model is built around accessibility, convenience, and physician oversight, allowing patients to access professional weight management care without requiring in-person clinic visits. According to CoreAge Rx, this approach reflects its commitment to providing modern healthcare solutions through digital technology.
CoreAge Rx further reports that the milestone of more than 300 patient reviews represents an important indicator of patient engagement and experience within its platform. The company states that patient feedback continues to inform its ongoing efforts to provide structured, physician-supervised weight management care through telehealth.
As telehealth adoption continues to expand, CoreAge Rx reports that its focus remains on maintaining a streamlined patient experience from onboarding through ongoing care. The company states that its review milestone reflects its continued commitment to delivering accessible, physician-guided weight management services through a fully online platform.
For more information, visit https://www.coreagerx.com/
Inquiries can be submitted through the official website contact page.
Media Contact
Organization: CoreAge Rx
Contact Person: Ella Jones
Website: https://www.coreagerx.com/
Email: Send Email
Contact Number: +19404004927
City: Wichita Falls
State: TX 76302
Country:United States
Release id:41548
Disclaimer: This content is provided for informational purposes only and does not constitute medical advice. Medical treatments require evaluation and prescription by licensed healthcare professionals.
The post Review Milestone: Why 300+ Patients Rated CoreAge Rx Among the Best in Online Weight Management Telehealth appeared first on King Newswire. This content is provided by a third-party source.. King Newswire makes no warranties or representations in connection with it. King Newswire is a press release distribution agency and does not endorse or verify the claims made in this release. If you have any complaints or copyright concerns related to this article, please contact the company listed in the ‘Media Contact’ section
About Author
Disclaimer: The views, suggestions, and opinions expressed here are the sole responsibility of the experts. No Digi Observer journalist was involved in the writing and production of this article.
Press Release
American Made GLP-1 Names CoreAge Rx As Best GLP-1 Provider for 2026
Miami, FL 33101, United States, 18th Feb 2026 – American Made GLP-1, a US- based healthcare resource dedicated to reviewing and comparing GLP-1 treatment providers, has released its latest rankings of telehealth platforms offering physician-supervised GLP-1 programs for weight management, naming CoreAge Rx as the #1 GLP-1 Provider and awarding the platform an outstanding 4.9 out of 5 rating. The independent review evaluated more than 10 U.S.-based telehealth providers and recognized CoreAge Rx with the designation “Editor’s Choice,” citing its medication quality, physician oversight, patient satisfaction, and comprehensive telehealth care model.

According to American Made GLP-1, the rankings were based on several key criteria, including the quality of GLP-1 medications prescribed, physician qualifications, treatment personalization, regulatory compliance, patient experience, and overall care quality. CoreAge Rx ranked at the top of the list due to its physician-supervised programs using FDA-approved GLP-1 medications such as semaglutide and tirzepatide, along with individualized treatment plans designed to support long-term weight management outcomes.
The rankings page published by American Made GLP-1 lists CoreAge Rx as its top recommendation, noting that the platform provides personalized telehealth-based treatment programs overseen by board-certified physicians with expertise in metabolic health and obesity medicine. The review highlights that CoreAge Rx offers a structured medical process that includes a comprehensive online health assessment, physician consultation, personalized treatment planning, and medication delivery directly to patients’ homes.
In its summary overview, American Made GLP-1 states that CoreAge Rx stands out among telehealth providers due to its commitment to personalized medical care, physician oversight, and ongoing patient monitoring. The platform’s telehealth model enables patients to begin treatment within approximately 24 to 48 hours following physician approval, allowing for timely access to medically supervised weight management care.
The editorial review identifies physician-guided treatment as a key factor in CoreAge Rx earning the #1 ranking. According to American Made GLP-1, CoreAge Rx connects patients with board-certified physicians who conduct comprehensive medical evaluations before prescribing treatment. These physicians develop individualized dosing protocols based on each patient’s medical profile and monitor patient progress throughout the treatment process to ensure safe and effective outcomes.
Medication quality and regulatory compliance were also highlighted as important ranking factors. CoreAge Rx prescribes GLP-1 medications that contain FDA-approved active ingredients, including semaglutide and tirzepatide, which are prepared by licensed compounding pharmacies that meet regulatory standards. American Made GLP-1 also notes that CoreAge Rx has earned LegitScript certification, confirming that the company meets strict requirements for telehealth safety, transparency, and pharmacy compliance.
American Made GLP-1 reports that CoreAge Rx’s weight management programs include ongoing physician supervision, progress monitoring, and personalized adjustments to treatment plans as needed. This continuous care model ensures that patients receive consistent medical oversight throughout their treatment journey, helping support sustainable and medically supervised weight management.
The review also emphasizes CoreAge Rx’s patient support infrastructure. According to American Made GLP-1, CoreAge Rx provides patients with access to dedicated care coordinators, nutritional guidance, and progress tracking tools. These services are designed to help patients remain engaged with their treatment plan and maintain consistency under physician supervision.
Shipping and accessibility were additional factors considered in the rankings. CoreAge Rx provides free standard shipping on prescribed medications, ensuring convenient access for patients nationwide. The telehealth platform serves eligible patients in most U.S. states, allowing individuals to receive physician-guided weight management care regardless of geographic location.
American Made GLP-1 also highlights reported patient outcomes associated with physician-supervised GLP-1 treatment programs. According to the review, patients participating in structured GLP-1 programs commonly experience measurable weight management progress over time. Reported data indicates that patients typically achieve a reduction of approximately 10 percent to 26 percent of body weight within 12 months under physician supervision, with many patients reporting improvements in energy levels and overall well-being.
The publication also notes that CoreAge Rx’s treatment programs are designed with flexibility in mind. Patients complete an initial consultation and comprehensive health evaluation, after which physicians determine eligibility and develop personalized treatment plans. CoreAge Rx offers semaglutide programs starting at $299 per month and tirzepatide programs starting at $399 per month, with physician supervision and ongoing support included as part of the program.
American Made GLP-1 describes itself as a trusted U.S.-based resource that provides information and independent comparisons of GLP-1 treatment providers. The organization states that its rankings are based on objective evaluation criteria, including medical quality, physician oversight, patient experience, and regulatory compliance, with the goal of helping patients make informed healthcare decisions.
With its 4.9 out of 5 rating and designation as the #1 GLP-1 Provider, CoreAge Rx emerged at the top of American Made GLP-1’s review of telehealth platforms offering physician-supervised GLP-1 programs. The recognition reflects the platform’s focus on medical oversight, treatment personalization, regulatory compliance, and patient-centered telehealth care for weight management.
For more info, visit: https://www.americanmadeglp1.com/reviews/coreage-rx
Media Contact
Organization: American Made GLP-1
Contact Person: Paul Hard
Website: https://www.americanmadeglp1.com/
Email: Send Email
Contact Number: +13035550187
City: Denver
State: CO 80202
Country:United States
Release id:41549
Disclaimer: This content is provided for informational purposes only and does not constitute medical advice. Medical treatments require evaluation and prescription by licensed healthcare professionals.
The post American Made GLP-1 Names CoreAge Rx As Best GLP-1 Provider for 2026 appeared first on King Newswire. This content is provided by a third-party source.. King Newswire makes no warranties or representations in connection with it. King Newswire is a press release distribution agency and does not endorse or verify the claims made in this release. If you have any complaints or copyright concerns related to this article, please contact the company listed in the ‘Media Contact’ section
About Author
Disclaimer: The views, suggestions, and opinions expressed here are the sole responsibility of the experts. No Digi Observer journalist was involved in the writing and production of this article.
-
Press Release20 hours ago
The New Architecture of Resilience: Why Ecosystem Design is the Secret to MENA’s Post-Conflict Recovery
-
Press Release6 days ago
300 Scientology Volunteers Distribute 500,000 Drug-Prevention Booklets during Winter Olympics
-
Press Release6 days ago
ECOBANK BACKS MEYA MINING WITH USD 25 MILLION FACILITY
-
Press Release6 days ago
Habitto to Raise Savings Account Interest Rate to 0.6% Effective February 1, 2026
-
Press Release6 days ago
OrbiSky awarded UK Space Agency contract for in-orbit manufacturing verification
-
Press Release4 days ago
George Washington University Launch Groundbreaking Public Certification Course on Mold Illness
-
Press Release1 week ago
Explora Books to Showcase William Sandberg-Maitland’s The Golden Codex at London Book Fair
-
Press Release4 days ago
Maui Helicopter Tours: Private Helicopter Tour Service In Hawaii
